Cu-Ag base alloy brazing filler material
    1.
    发明授权
    Cu-Ag base alloy brazing filler material 失效
    Cu-Ag基合金钎料

    公开(公告)号:US4416853A

    公开(公告)日:1983-11-22

    申请号:US373498

    申请日:1982-04-16

    IPC分类号: B23K35/30 C22C9/00

    CPC分类号: B23K35/302

    摘要: A Cu-Ag alloy brazing filler material with low Ag content that exhibits excellent brazability and has a low vapor pressure is disclosed. The filler material comprises 5 to 35% by weight of Ag, 2.5 to 13% by weight of Si, with the balance being Cu and incidental impurities. The properties of the filler material can be improved further by addition of at least one element selected from the group consisting of Sn, In, Fe, Ni, Co, B and Li.

    摘要翻译: PCT No.PCT / JP81 / 00189 Sec。 371日期:1982年4月16日 102(e)日期1982年4月16日PCT申请日1981年8月25日PCT公布。 第WO82 / 00790号公报 1982年3月18日公开了一种具有优异的钎焊性和低蒸气压的低Ag含量的Cu-Ag合金钎焊料。 填充材料包含5至35重量%的Ag,2.5至13重量%的Si,余量为Cu和附带的杂质。 通过添加选自Sn,In,Fe,Ni,Co,B和Li中的至少一种元素,可以进一步提高填充材料的性能。

    Cu-Ag-Si Base alloy brazing filler material
    2.
    发明授权
    Cu-Ag-Si Base alloy brazing filler material 失效
    Cu-Ag-Si基合金钎焊料

    公开(公告)号:US4411864A

    公开(公告)日:1983-10-25

    申请号:US406236

    申请日:1982-07-30

    CPC分类号: B23K35/302

    摘要: A Cu-Ag alloy brazing material that exhibits excellent cold workability, brazability and has a low vapor pressure is disclosed. The filler material comprises more than 35 to 50% by weight of Ag, 2.2 to 6% by weight of Si, with the balance being Cu and incidental impurities. The properties of the filler material can be improved further by addition of at least one element selected from the group consisting of Sn, In, Fe, Ni, Co, B and Li.

    摘要翻译: PCT No.PCT / JP81 / 00338 Sec。 371日期1982年7月30日 102(e)1982年7月30日PCT PCT 1991年11月18日PCT公布。 出版物WO82 / 02013 日期:1982年6月24日。公开了一种表现出优异的冷加工性,钎焊性和低蒸气压的Cu-Ag合金钎焊材料。 填料含有35〜50重量%的Ag,2.2〜6重量%的Si,余量为Cu和杂质。 通过添加选自Sn,In,Fe,Ni,Co,B和Li中的至少一种元素,可以进一步提高填充材料的性能。

    Stabilized human IgG2 and IgG3 antibodies
    8.
    发明授权
    Stabilized human IgG2 and IgG3 antibodies 有权
    稳定的人IgG2和IgG3抗体

    公开(公告)号:US08716451B2

    公开(公告)日:2014-05-06

    申请号:US11794950

    申请日:2006-01-12

    IPC分类号: C07K16/00 C12N15/00

    摘要: It is intended to provide highly stable variants of human antibody IgG2 and IgG3 subclasses. The present invention provides an IgG heavy chain comprising the constant region of a human IgG2 heavy chain having at least a substitution of Y for F at the 300th position, L for V at the 309th position, or A for T at the 339th position designated by the EU index of Kabat et al. and an IgG heavy chain comprising the constant region of a human IgG3 heavy chain having at least a substitution of K for N at the 392nd position or V for M at the 397th position designated by the EU index of Kabat et al. The present invention also provides monoclonal antibodies comprising these heavy chains.

    摘要翻译: 旨在提供人抗体IgG2和IgG3亚类的高度稳定的变体。 本发明提供一种IgG重链,其包含人IgG2重链的恒定区,其在第300位具有至少取代F的F,在第309位具有至少取代F的L,在第309位具有至少取代F的第三十九位, 欧盟指数Kabat等 和IgG重链,其包含人类IgG3重链的恒定区,在Kabat等人的EU指数指定的第397位具有至少在第392位具有K取代为N或V代表M。 本发明还提供了包含这些重链的单克隆抗体。

    AGONIST ANTIBODY TO HUMAN THROMBOPOIETIN RECEPTOR
    9.
    发明申请
    AGONIST ANTIBODY TO HUMAN THROMBOPOIETIN RECEPTOR 审中-公开
    人类抗抑郁药受体的激素抗体

    公开(公告)号:US20130053547A1

    公开(公告)日:2013-02-28

    申请号:US13543183

    申请日:2012-07-06

    IPC分类号: C07K16/00

    摘要: This invention provides an agonist antibody to a human thrombopoietin receptor (human c-Mpl), and pharmaceutical compositions comprising the same for use in treatment of thrombocytopenia. The disclosed agonist antibody comprises (1) antibody constant regions comprising heavy and light chain constant regions, each of which may optionally contain domain substitutions, or may contain deletions, substitutions, additions, or insertions of amino acid residues, and (2) antibody variable regions capable of binding to and activating a human thrombopoietin receptor. The-agonist antibody further induces colony formation at a concentration of 10,000 ng/ml or lower, and has a maximal activity at least 50% higher than that of PEG-rHuMGDF and an 50% effective concentration (EC50) of 100 nM or less.

    摘要翻译: 本发明提供了对人类血小板生成素受体(人c-Mpl)的激动剂抗体,以及包含其用于治疗血小板减少症的药物组合物。 所公开的激动剂抗体包含(1)包含重链和轻链恒定区的抗体恒定区,每个区可任选地含有结构域取代,或可含有氨基酸残基的缺失,替换,添加或插入,和(2)抗体可变 能够结合并激活人血小板生成素受体的区域。 激动剂抗体进一步诱导浓度为10,000ng / ml或更低的集落形成,并且具有比PEG-rHuMGDF高至少50%的最大活性和100nM或更低的50%有效浓度(EC 50)。

    BLOOD PRESSURE INFORMATION MEASUREMENT DEVICE CUFF AND BLOOD PRESSURE INFORMATION MEASUREMENT DEVICE PROVIDED THEREWITH
    10.
    发明申请
    BLOOD PRESSURE INFORMATION MEASUREMENT DEVICE CUFF AND BLOOD PRESSURE INFORMATION MEASUREMENT DEVICE PROVIDED THEREWITH 有权
    血液压力信息测量装置和血液压力信息测量装置

    公开(公告)号:US20120330169A1

    公开(公告)日:2012-12-27

    申请号:US13538371

    申请日:2012-06-29

    IPC分类号: A61B5/022

    CPC分类号: A61B5/02233 A61B5/02141

    摘要: In a blood pressure information measurement device cuff, a first flexion point and a second flexion point at which a curvature radius changes are provided in a curler, and a straight line-shaped connection portion is provided between the first flexion point and the second flexion point so as to be located inside a curve formed by extending a first curved portion and a second curved portion that are located at the ends of the curler at the first flexion point and the second flexion point, according to the respective curvatures. Through this, it is possible to provide a blood pressure information measurement device cuff, and a blood pressure information measurement device provided with such a cuff, that can reduce error in a blood pressure measurement by reducing errors in changes in the volume of a fluid bladder.

    摘要翻译: 在血压信息测量装置袖带中,在卷曲器中设置曲率半径变化的第一屈曲点和第二屈曲点,并且在第一屈曲点和第二屈曲点之间设置直线状连接部 以便位于通过根据各自的曲率在第一弯曲点和第二屈曲点处延伸位于卷曲器的端部处的第一弯曲部分和第二弯曲部分所形成的曲线内部。 通过这种方式,可以提供一种血压信息测量装置袖带和具有这种袖带的血压信息测量装置,其可以通过减少流体囊体积的变化的误差来减少血压测量的误差 。